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Abstract Lymphotoxin-L receptor (LTLR) is a member of the
tumor necrosis factor receptor (TNFR) superfamily that acti-
vates nuclear factor-UB (NF-UB) through the IUB kinase (IKK)
complex, the core of which is comprised of IKK1, IKK2 and
NF-UB essential modulator (NEMO). We demonstrate here
that the LTLR signaling to NF-UB activation does not neces-
sarily require NEMO, which is essential for TNFR signaling. In
the absence of NEMO, the p50 and RelB, but not RelA subunits
of NF-UB are found in the nuclear DNA binding complexes
induced by the LTLR signaling. Our results thus disclose
NEMO-independent NF-UB activation by LTLR.
0 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Lymphotoxin-L receptor (LTLR), a member of the tumor
necrosis factor receptor (TNFR) superfamily, was identi¢ed as
a molecule required for the development of lymphoid organs
[1^5]. LTLR knockout mice showed a phenotype that in-
cluded the lack of lymph nodes and Peyer’s patches, and a
disorganized splenic architecture [2]. LTLR binds speci¢cally
to two ligands: the membrane form of lymphotoxin LTK1L2
[4] and LIGHT, a recently identi¢ed member of the TNF
superfamily [6]. These ligands activate nuclear factor-UB
(NF-UB) following receptor ligation [7]. In addition, ectopic
expression of LTLR, like other members of the TNFR super-
family, leads to the activation of NF-UB [8]. LTLR-mediated
activation of NF-UB is supposed to be important for the de-
velopment of lymphoid organs, because disruption or muta-
tion of the NF-UB-inducing kinase (NIK) gene in mice re-
sulted in a similar phenotype as was observed in LTLR-
knockout mice [9]. However, the molecular mechanisms that
underlie the NF-UB signaling pathway mediated by LTLR are
still unclear.
IUB kinase (IKK) activation is a crucial step in the stimu-
lation of NF-UB, which regulates many genes that participate
in the immune, in£ammatory, oncogenic or apoptotic process-
es [10,11]. The IKK complex is composed of two catalytic
subunits, IKK1/K and IKK2/L, and a regulatory subunit,
NF-UB essential modulator (NEMO)/IKKQ [12^22]. Activa-
tion of IKK leads to a phosphorylation of p105, p100 and
the IUB family proteins, resulting in nuclear translocation of
NF-UB hetero/homodimers [10]. It is known that IKK activa-
tion is indispensable for NF-UB activation in response to stim-
ulation by various cytokines including TNF-K and interleu-
kin-1L (IL-1L). Previous studies showed that the stimulation
with agonistic antibody against LTLR failed to phosphory-
late IUBK in mouse embryo ¢broblasts (MEFs) derived from
mice lacking IKK1 [23]. Thus, IKK activation is indispens-
able for LTLR-mediated NF-UB activation. We reported
previously that stimulation by cytokines, such as TNF-K, lipo-
polysaccharide (LPS), or IL-1L, failed to activate IKK
in NEMO-de¢cient cells [22]. However, it is not known if
NEMO is required for the LTLR-induced IKK activation.
To address this issue, we used NEMO-de¢cient rat ¢broblasts
previously used for complementation cloning of NEMO
[22].
The cytoplasmic domain of LTLR, like other members of
the TNFR superfamily, does not contain consensus amino
acid sequences characteristic of domains with enzymatic ac-
tivity. Thus, it is likely that NF-UB activation through LTLR
is initiated by the proteins interacting with LTLR. The
TNFR-associated factor (TRAF) family proteins were iden-
ti¢ed as signal transducers that bound to several members
of the TNFR superfamily and other cytokine receptors,
leading to the activation of NF-UB and mitogen-activated
protein kinases (MAPKs) [24]. TRAF2, TRAF5 and
TRAF6 were shown to activate NF-UB and to be involved
in NF-UB activation mediated by these receptors [24]. Pre-
vious reports showed that the cytoplasmic domain of LTLR
bound to TRAF2, 3, 4, and 5 [8,24^28]. However, the
functional signi¢cance of these TRAFs in LTLR-mediated
NF-UB signaling is not fully understood. We assessed how
the TRAFs contribute to the NF-UB activation by LTLR,
using MEFs derived from mice lacking both TRAF2 and
TRAF5 [25].
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2. Materials and methods
2.1. Materials
Anti-NEMO antibody was described previously [22]. Anti-actin
antibody (C-2), anti-IKK1 antibody (H744), anti-IKK2 antibody
(H-470), anti-p52 antibody (K-27) and anti-c-Rel antibody (N) were
purchased from Santa Cruz (Santa Cruz, CA, USA). Anti-Flag anti-
body (M2) was purchased from Sigma (St. Louis, MO, USA). Anti-
p50, anti-RelA and anti-RelB sera were kindly provided by Dr. Israe«l
(Institut Pasteur, Paris, France). Recombinant wild type and S32A/
S36A mutant GST-IUBK (1^72) proteins were prepared as described
previously [22]. All the reagents were purchased from Sigma unless
otherwise noted.
2.2. Plasmids
IgU-ConAluc and EF1-lacZ vector were described previously [29]. A
SacI/BglII DNA fragment containing the cytomegalovirus early en-
hancer-promoter, U3-deleted murine leukemia virus long terminal re-
peat and packaging signal was excised from pRxhCD25iN [30], and
subcloned into the same enzymatic site of pMX-IRES-EGFP [31],
generating pMRX-IRES-EGFP. The puromycin resistance gene was
ampli¢ed by PCR using pPUR (Clontech) as a template. The EGFP
gene of pMRX-IRES-EGFP was replaced by the puromycin resis-
tance gene, generating pMRX-IRES-puro. The cDNA of LTLR was
ampli¢ed by PCR using pFlag/huLTLR [33] as a template. This
cDNA was inserted into the pcDNA3-Flag or pMRX-IRES-puro
vector. These vectors are referred to as pcDNA3 Flag-LTLR and
pMRX-Flag-LTLR-puro, respectively. A cDNA fragment of
TNFR1 ampli¢ed by PCR using pADB-TR55 [34] as a template
was inserted into the pcDNA3-Flag vector, generating pcDNA3-
Flag-TNFR1. All these PCR-ampli¢ed fragments were veri¢ed by
sequencing.
2.3. Cell culture, transfection of plasmids and infection of retrovirus
5R is a NEMO-de¢cient subline of Rat-1 as described previously
[22]. MEFs lacking IKK1 and IKK2 were kindly provided by Dr.
Verma (Salk Institute, San Diego, CA, USA) [15]. MEFs lacking
TRAF2 and TRAF5 were described previously [25]. PLAT-E cells
were described previously [32]. Rat-1, 5R, MEFs and PLAT-E cells
were maintained in DMEM supplemented with 10% fetal calf serum,
100 U/ml of penicillin G and 100 Wg of streptomycin. Rat-1 and 5R
cells were transfected using the calcium phosphate coprecipitation
method. MEFs and PLAT-E cells were transfected using fugene 6
transfection reagent (Roche, Indianapolis, IN, USA) according to
the manufacturer’s instructions. For production of retroviruses, cul-
ture supernatants of PLAT-E cells transfected with pMRX-IRES-
puro or pMRX-Flag-LTLR-IRES-puro were collected 72 h after
transfection. Rat-1 and 5R cells were infected in the presence of 10
Wg/ml of polybrene.
2.4. Reporter gene assay
Cells were transfected with 250 ng of IgU-ConAluc and 250 ng of
EF1-lacZ along with 100 ng of e¡ector plasmids. Cells were lysed in
lysis bu¡er (25 mM Tris^HCl, 8 mM MgCl2, 1 mM dithiothreitol
(DTT), 1% Triton X-100, 15% glycerol). Luciferase activities were
determined as previously described and normalized on the basis of
L-galactosidase activity [22].
2.5. Preparation of cytoplasmic and nuclear extracts
Cells were suspended in hypotonic bu¡er (10 mM HEPES [pH 7.8],
10 mM KCl, 2 mM MgCl2, 1 mM DTT, and 0.1 mM ethylenedi-
aminetetra-acetate (EDTA)) supplemented with protease and phos-
phatase inhibitors, 0.1 mM phenylmethylsulfonyl £uoride (PMSF),
1 Wg/ml leupeptin, 1 Wg/ml aprotinin, 100 WM Na3VO4 and 20 mM
L-glycerophosphate. After a 10 min incubation at 4‡C, Nonidet P-40
was added to 1%. A soluble and an insoluble fraction were separated
by a centrifugation. The supernatant was recovered as cytoplasmic
extract. The nuclear pellet was washed with hypotonic bu¡er and
resuspended in extraction bu¡er (50 mM HEPES [pH 7.8], 50 mM
KCl, 350 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.1 mM PMSF,
1 Wg/ml leupeptin, 1 Wg/ml aprotinin and 2.5% glycerol). After a 30 min
incubation at 4‡C, with occasional agitation, DNA pellets were elim-
inated by centrifugation. The supernatant was recovered as nuclear
extract.
2.6. Kinase assay
Cytoplasmic extracts (400 Wg) were subjected to immunoprecipita-
tion with anti-IKK1 or IKK2 antibody in TNT bu¡er (Tris^HCl 20
mM [pH 7.5], NaCl 200 mM, Triton X-100 1%) and collected on
protein G-Sepharose beads. Kinase reactions were conducted for 30
min at 30‡C in the presence of 5 WCi of [Q-32P]ATP and wild type or
S32A/S36A mutant GST-IUBK(1^72) protein as substrates. The reac-
tion products were resolved on 12% sodium dodecyl sulfate (SDS)^
polyacrylamide gels and revealed by autoradiography.
2.7. Western blot analysis
Cytoplasmic extracts (50 Wg) were fractionated on 8^12% SDS^
polyacrylamide gels, transferred onto Immobilon membranes (Milli-
pore), and blots were revealed with an enhanced chemiluminescence
detection system (ECL, Amersham).
2.8. Electrophoretic mobility shift assay (EMSA)
Nuclear extracts (5 Wg) were incubated in 20 Wl of binding bu¡er (10
mM HEPES [pH 7.8], 100 mM NaCl, 1 mM EDTA, 2.5% glycerol),
1 Wg of poly[d(I-C)], and 0.5 ng 32P-labeled UB probe derived from the
H-2Kb promoter [35] or 32P-labeled Oct-1 probe [36] and incubated
for 30 min at room temperature. For supershift assays, nuclear ex-
tracts were incubated with speci¢c antibodies for 30 min on ice before
incubation with the labeled probe. Samples were run on a 5% poly-
acrylamide gel containing 2.5% glycerol in 0.5UTBE and revealed by
autoradiography.
3. Results
3.1. LTLR can induce NF-UB-dependent transcription
independently of NEMO
To investigate a role of NEMO in the LTLR-mediated NF-
Fig. 1. LTLR, but not TNFR1, induces NF-UB-dependent transcrip-
tion independently of NEMO. A: Rat-1 and 5R cells were trans-
fected with 100 ng of pcDNA3-Flag (control; Ctl), pcDNA3-Flag-
TNFR1 or pcDNA3-Flag-LTLR along with 0.25 Wg of IgU-ConAluc
and EF1-lacZ. The cells were harvested and lysed in lysis bu¡er 36
h after transfection. The cellular extracts were subjected to reporter
gene assay. The UB-dependent luciferase activity was normalized
based on the L-galactosidase activity. The values shown are
meansTS.D. from three separate transfections. The experiment was
repeated twice with similar results being obtained. B: NEMO ex-
pression in Rat1 and 5R cells detected by anti-NEMO polyclonal
antibodies.
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UB signaling pathways, we used 5R cells, which lack NEMO
and were used in complementation cloning of NEMO (Fig.
1B). Reporter gene assays showed that ectopic expression of
LTLR and TNFR1 induced UB-dependent transcription to
similar extents in Rat-1 expressing wild type NEMO (Fig.
1A). Notably, LTLR induced UB-dependent transcription in
5R cells, albeit to a lesser extent (Fig. 1A). In contrast,
TNFR1-induced UB-dependent transcription was severely im-
paired in 5R cells (Fig. 1A). Thus, LTLR, when ectopically
expressed, does not require NEMO for NF-UB activation.
3.2. LTLR signaling induces IKK activation in the absence of
NEMO
The results that LTLR did not necessarily require NEMO
for NF-UB activation raised a possibility that ectopic expres-
sion of LTLR might activate NF-UB through pathways that
did not involve IKK1 or IKK2 as was observed in UV-treated
cells [37]. To assess a requirement of IKK activation for the
LTLR-mediated NF-UB signaling, we tested MEFs de¢cient in
both IKK1 and IKK2 for NF-UB activation by LTLR. Re-
porter gene assays revealed that LTLR failed to induce UB-
dependent transcription in the absence of IKK1 and IKK2
(Fig. 2). This suggested that LTLR activated IKKs in the
absence of NEMO, and prompted us to determine a kinase
activity induced by LTLR in 5R cells. Immunoprecipitation of
IKK1 followed by in vitro kinase reaction demonstrated sig-
ni¢cantly elevated IKK activity in Rat-1 as well as in 5R cells
infected with retroviruses capable of expressing LTLR (Fig.
3). Lack of phosphorylation of a mutant substrate established
the speci¢city of the experiment. Kinase assay coupled with
immunoprecipitation of IKK2 revealed weak IKK activation
by LTLR compared to that by TNF-K (data not shown) in
Rat-1 and 5R cells expressing LTLR. Thus, LTLR can pref-
erentially activate IKK1 in a NEMO-independent manner.
Fig. 2. IKK activation was required for LTLR-induced UB-depen-
dent transcription. Wild type or IKK1/IKK2 double knockout
MEFs were transfected with 100 ng of pcDNA3-Flag (control; Ctl)
or pcDNA3-Flag-LTLR along with 0.25 Wg of IgU-ConAluc and
EF1-lacZ. The cells were harvested and lysed in lysis bu¡er 22 h
after transfection. Relative luciferase units were determined as de-
scribed in Fig. 1. The values shown are meansTS.D. from three
separate transfections. The experiment was repeated twice with simi-
lar results being obtained.
Fig. 3. LTLR increased IKK activity independently of NEMO. Rat-1 and 5R cells were infected with retroviruses produced by transfection of
PLAT-E cells with either pMRX-IRES-puro (control; Ctl) or pMRX-Flag-LTLR-IRES-puro. The cells were harvested 48 h after infection. The
cytoplasmic extracts were subjected to kinase assay and Western blot analysis. The endogenous IKK complex was immunoprecipitated by anti-
IKK1 or IKK2 antibody and subjected to in vitro kinase reaction. Wild type or S32A/S36A mutant GST-IUBK protein was used as substrate.
To control for equal amounts of IKK, Western blot analysis was performed, using anti-IKK1 or anti-IKK2 antibody respectively. Expression
of Flag-LTLR was assessed by Western blot analysis with anti-Flag monoclonal antibody. The asterisks indicate a non-speci¢c band. As a load-
ing control, amounts of actin were shown by Western blot analysis with anti-actin antibody. These experiments were carried out twice. The re-
sults were essentially reproducible.
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3.3. LTLR directs nuclear translocation of p50 and RelB, but
not of RelA in the absence of NEMO
EMSA showed increased NF-UB DNA binding activity in
Rat-1 and 5R cells expressing LTLR (Fig. 4A). To determine
the subunit composition of the DNA binding complexes, we
performed supershift assays using speci¢c antibodies or anti-
serum against p50, p52, RelA, RelB or c-Rel, which are com-
mon components of NF-UB (Fig. 4B). Anti-p50 antiserum
supershifted almost completely the faster migrating complexes
in Rat-1 and 5R cells. Anti-RelB antiserum also supershifted
the faster migrating complexes in Rat-1 and 5R cells express-
ing LTLR, while it had no appreciable e¡ect on complexes
induced in Rat-1 cells stimulated with TNF-K for 30 min (Fig.
4C), indicating the speci¢city of the antiserum and a distinct
mechanism of NF-UB activation by LTLR. Anti-RelA antise-
rum weakly supershifted the slowly migrating complexes in
Rat-1 cells, but not those at the corresponding position in
5R cells, although the RelA subunit was similarly expressed
in Rat-1 and 5R cells (Fig. 4D). Anti-p52 antibody (K-27;
Santa Cruz) or anti-c-Rel antibody (N; Santa Cruz) did not
supershift the NF-UB complex either in Rat-1 or in 5R cells
(Fig. 4B).
3.4. TRAFs are required for LTLR-induced UB-dependent
transcription
We ¢nally asked if the observed NEMO-independent IKK
Fig. 4. LTLR induced nuclear localization of RelB and p50 independently of NEMO. Nuclear extracts were prepared from the cells used in
Fig. 3. A: Nuclear extracts prepared from control or LTLR-expressing cells were incubated with 32P-labeled UB or Oct-1 probe and subjected
to EMSA. B: The extracts were incubated with 32P-labeled UB probe in the absence or presence of pre-immune serum (PI), anti-p50 serum,
anti-RelA serum, anti-RelB serum, anti-p52 antibody, anti-c-Rel antibody or control rabbit IgG, and then subjected to supershift assay. C: Nu-
clear extract of Rat-1 cells stimulated with TNF-K for 30 min was incubated with either PI or anti-RelB antiserum and 32P-labeled UB probe,
and then analyzed by EMSA. D: RelA expression in Rat-1 and 5R cells detected by anti-RelA serum. These experiments were carried out
twice. The results were essentially reproducible.
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activation is linked to any particular upstream regulators.
Recent studies showed that TRAF2, 3, 4 and 5, mediators
of cytokine receptor-mediated signaling, could bind to
LTLR. Since TRAF2 and TRAF5 have been shown to acti-
vate NF-UB, we examined the requirement of TRAF2 and
TRAF5 in the LTLR-mediated NF-UB signaling. Reporter
gene assays revealed that LTLR-induced UB-dependent tran-
scription was readily detected in wild type MEFs, but was
severely impaired in MEFs derived from mice de¢cient in
both TRAF2 and TRAF5 (Fig. 5).
4. Discussion
Targeted disruption of IKK1 and IKK2 revealed that IKK
activation was indispensable for NF-UB activation through a
variety of cell surface receptors [13^15,19]. We had previously
identi¢ed NEMO as a regulatory subunit of the IKK complex
[22]. In this study, we showed that the LTLR signaling could
activate IKK in a NEMO-independent manner, resulting in
NF-UB activation. As far as we know, this is the ¢rst report
showing that a cytokine receptor protein can activate NF-UB
through IKK in the absence of NEMO. In contrast, TNFR1
was unable to activate NF-UB in 5R cells. Thus, the LTLR-
induced NF-UB signaling is di¡erent from that induced by
TNFR1 at least in the usage of NEMO.
The dependence on NEMO in IKK activation appears to be
linked to the usage of the IKK catalytic subunits. There is
growing evidence showing that IKK1 and IKK2 are di¡er-
entially regulated by cytokine receptor-speci¢c intracellular
signal transducers and play distinct roles in the NF-UB signal-
ing pathway [9,10,23,24]. Previous studies revealed that
TNFR1 failed to activate NF-UB in IKK2-de¢cient cells. Sig-
naling by other cytokines, such as LPS and IL-1L, also re-
quired IKK2 to activate NF-UB [38]. Moreover, the Tax pro-
tein of human T cell leukemia virus type I preferentially
phosphorylates IKK2. We and other researchers demon-
strated that NEMO played an indispensable role for the cy-
tokine- or Tax-induced NF-UB activation [20^22]. On the oth-
er hand, LTLR signaling to NF-UB activation was reported to
depend predominantly on IKK1 and failed to induce phos-
phorylation of IUBK in IKK1-de¢cient cells [23]. Indeed,
LTLR-induced IKK activity revealed by immunoprecipitation
of IKK2 was considerably weak (Fig. 3). A recent study by
Hu et al. [39] demonstrated a role for IKK1 in keratinocyte
di¡erentiation that does not depend on its kinase activity or
binding to NEMO. Our present results of NEMO-indepen-
dent IKK activation by LTLR suggest that the NEMO de-
pendence is linked to di¡erential activities of IKK1 and
IKK2.
MAP3Ks (mitogen-activated protein kinase kinase kinases)
are believed to constitute important upstream regulators of
IKK in the NF-UB signaling pathway [9,23,40,41]. NIK was
identi¢ed as TRAF2-interacting MAP3K that phosphorylated
IKK [40] and was found to mediate the LTLR-induced NF-
UB activation, because mice de¢cient or mutant in NIK
showed a phenotype similar to that of LTLR-de¢cient mice
[9]. We also observed that a dominant negative form of NIK
signi¢cantly impaired UB-dependent transcription induced by
LTLR in Rat-1 and 5R cells (data not shown). On the other
hand, a recent genetic study disclosed that MAP3K-3 is an
essential mediator of the TNF-K-induced NF-UB activation
[41]. Thus, it is plausible that di¡erential usage of MAP3K
may determine the dependence of NEMO and the IKK sub-
unit(s) activation.
Mammalian cells are known to express ¢ve NF-UB family
members: RelA, RelB, c-Rel, p100/p52 and p105/p50 [10]. In
the present study, we showed that the LTLR-induced NF-UB
complexes contained the RelB and p50 subunits in NEMO-
de¢cient cells. RelB di¡ers in its regulation from the other two
NF-UB activators, RelA and c-Rel, which are controlled by
IUB proteins [10,42]. Previous studies revealed that p100 is
associated with RelB and inhibits its nuclear localization,
but IUBK, IUBL, IUBO or p105 are not [43]. Processing of
p100 is regulated by IKK1 and NIK, both of which are in-
dispensable for the LTLR-induced NF-UB activation [43^45].
In addition, ectopic expression of NIK caused NF-UB activa-
tion in 5R (data not shown), consistent with a previous report
by Xiao et al. [46] that showed NEMO-dependent and -inde-
pendent inducible p100 processing by Tax and NIK, respec-
tively. Thus, it appears likely that the p100 processing induced
by NIK couples with a NEMO-independent nuclear translo-
cation of RelB in cells expressing LTLR. Notably, we found
that LTLR expression induced nuclear translocation of the
RelA subunit in Rat-1 cells, but not in 5R cells. These results
indicated that NEMO plays an essential role for nuclear trans-
location of the RelA subunit following phosphorylation and
degradation of the IUB proteins and that the LTLR signals to
the IKK complex diverge into NEMO-dependent and -inde-
pendent pathways.
Finally, we asked how TRAF2 and TRAF5 are involved in
the LTLR-mediated NF-UB signaling pathway, since they are
known to be required for the TNFR1 signaling to NF-UB [25].
TRAF2- or TRAF5-de¢cient mice showed secondary lym-
phoid tissue development [47], which was de¢cient in LTLR-
knockout mice. It was supposed to be di⁄cult to determine
the individual role of each TRAF in the LTLR-induced NF-
UB activation, because TRAF2 and TRAF5 could be redun-
Fig. 5. LTLR-induced UB-dependent transcription was severely im-
paired in TRAF2 and TRAF5 double knockout MEFs. Wild type
or TRAF2/TRAF5 double knockout MEFs were transfected with
100 ng of pcDNA3-Flag (control; Ctl) or pcDNA3-Flag-LTLR
along with 0.25 Wg of IgU-ConAluc and EF1-lacZ. The cells were
harvested and lysed in lysis bu¡er 22 h after transfection. Relative
luciferase units were determined as described in Fig. 1. The values
shown are meansTS.D. from three separate transfections. The ex-
periment was repeated twice with similar results being obtained.
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dant in this signaling pathway as observed for TNF-K [25]. To
assess the requirement of these TRAFs, we used MEFs de¢-
cient in both TRAF2 and TRAF5 in the present study and
showed that the LTLR-induced NF-UB activation was greatly
impaired in these cells. Thus, it seems likely that the NEMO-
independent and -dependent pathways from LTLR to IKK
activation diverge at a step downstream of TRAF2 and/or
TRAF5. Nevertheless, a tiny reporter gene activation by
LTLR expression in TRAF2 and TRAF5 double knockout
MEFs and a previous report that a truncated form of
LTLR lacking the putative TRAF binding domain still acti-
vated NF-UB leave open the questions whether certain mole-
cule(s) other than TRAF2 and TRAF5 may mediate IKK
activation by LTLR [8] and whether such activity has any
link to the NEMO-dependent or -independent LTLR signal-
ing.
Elucidation of the mechanism of the NEMO-independent
IKK activation by LTLR will facilitate a better understanding
of IKK activation, which should eventually enable us to know
how di¡erent modes of IKK activation ¢nally result in diverse
gene regulation by NF-UB.
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